Infection Biology The University of Manchester

Overview

Infectious disease remains a major cause of human death but the efficacy of antimicrobial interventions continues to decline. The discovery of novel preventative and therapeutic interventions now critically dependent upon a detailed mechanistic understanding of disease processes, their impact upon human pathobiology and the feasibility of therapeutically targeting such mechanisms.  

The  Infection Biology course The University of Mancheste will equip you with:

• a detailed theoretical and practical understanding of molecular microbiology and antimicrobial immunology;
• a thorough understanding of methods for analysing the biological functions and physiological relevance of microbial virulence factors and host responses to pathogenic challenge; 
• a working knowledge of mechanistic approaches to problem-solving in molecular and cellular biomedical science;
• an understanding of a wide repertoire of cutting edge scientific methods including flow cytometry, single cell technologies, imaging and proteomics;

• transferable skills in critical reasoning and reflection, collaborative team working, scientific communication, use of IT/health informatics, innovation in the application of knowledge to practice and logical/systematic approaches to solving problems and making decisions.

Career opportunities

This course is designed for students who wish to pursue a career in biomedical research.

The majority of our MRes students will go on to undertake PhD studies at The University of Manchester and elsewhere, or will continue their career in the industrial sector where the rapid recent expansion of genomic science and the ever-increasing demand for cell-based analysis and experimentation emphasises the requirement for suitably trained research graduates.

Intercalating medical students from Manchester and elsewhere will benefit from the MRes Infection Biology if they are interested in careers addressing the many challenges of hospital and community acquired infectious disease, antibiotic resistance and novel antimicrobial strategy.